Medicalsystem Biotechnology Co.,Ltd.’s Net Profit Rose 18% in First Half of 2023

Medicalsystem Biotechnology Co.,Ltd. (美康生物科技股份有限公司) (300439.SZ) reported a net profit of 169.7 million yuan in the first half of 2023, up 18% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, down 24.3% year-on-year.

At the end of the reporting period, it had 3.5 billion yuan in total assets and 893 million yuan in total liabilities, with a liability-to-asset ratio of 25.4%.